Skip to main content
Clinical Trials/NCT03178773
NCT03178773CompletedPhase 2

Trial to EXamine Text Messaging for Diabetes in ED Patients Incorporating Social Support - Intervention With Washout

University of Southern California1 site in 1 country166 target enrollmentStarted: July 18, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
166
Locations
1
Primary Endpoint
Change in HBA1c From Baseline

Study Overview

Brief Summary

This is an intervention to study incorporating social support into mHealth interventions for low-income, ED patients with diabetes

Detailed Description

Diabetes has disproportionately affected the Latino population. TExT-MED (Trial to Examine Text Message for Emergency Department Patients with Diabetes) is a locally designed, successful mobile health (mHealth) intervention for low income Latinos with diabetes. Social support interventions have likewise been successful at improving patient self-efficacy and disease management but are limited in scale due to two key obstacles: 1) requirements of in-person training of family and friends to be supporters and 2) the need to coordinate schedules and physical location between the patient and their supporter. mHealth can overcome these obstacles by allowing supporters to be trained remotely via a mobile platform and by allowing communication between a patient and supporter to occur at any time or place. The proposed intervention leverages the success of TExT-MED by augmenting the program with a social supporter that each patient can select from his or her own social support system (Family And friend Network Supporters (FANS)), creating TExT-MED+FANS. This is a 12 month, randomized study of this intervention. At the completion of the trial, we will evaluate the user experience with TExT-MED+FANS, and the impact of TExT-MED+FANS on patient motivation, self-efficacy and behaviors through a qualitative analysis of semi-structured individual interviews.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •HbA1c>8.5
  • •Social support person identified and contacted

Exclusion Criteria

  • •unable to consent
  • •does not speak/read English or Spanish

Arms & Interventions

TExT-MED only

Active Comparator

Patients receive SMS-textmessage curriculum to improve self0-efficacy and self care for diabetes. A patient-identified family member receives a social support curriculum (FANS) in traditional booklet form.

Intervention: TExT-MED (Behavioral)

TExT-MED+FANS

Experimental

Patients receive SMS-textmessage curriculum to improve self0-efficacy and self care for diabetes. A patient-identified family member receives a social support curriculum (FANS) by SMS-text-message synchronized by time and content.

Intervention: TExT-MED (Behavioral)

TExT-MED+FANS

Experimental

Patients receive SMS-textmessage curriculum to improve self0-efficacy and self care for diabetes. A patient-identified family member receives a social support curriculum (FANS) by SMS-text-message synchronized by time and content.

Intervention: FANS (Behavioral)

Outcomes

Primary Outcomes

Change in HBA1c From Baseline

Time Frame: 6 Months

Glycemic control is measured by hemoglobin A1C collected at point-of-care from an Afinion AS100 capillary point of care machine. The Afinion machine has excellent point of care correlation with laboratory values. As a surrogate for average glycemic control over the previous 3 months and with correlation with clinical outcomes, hemoglobin A1c is a marker of overall clinical disease management. Change is baseline value minus follow up value.

Secondary Outcomes

  • Change in Diabetes Care Profile Support From Baseline(6 Months)
  • Change in Fatalism From Baseline(6 Months)
  • Change in Healthcare Utilization From 6 Months to 12 Months(12 Months)
  • Change in HBA1c From 6 Months to 12 Months(12 months)
  • Change in BMI From 6 Months to 12 Months(12 Months)
  • Change in Systolic Blood Pressure From Baseline(6 Months)
  • Change in Diastolic Blood Pressure From Baseline(6 Months)
  • Change in Abdominal Circumference From Baseline(6 Months)
  • Change From Abdominal Circumference From 6 Months to 12 Months(12 Months)
  • Change in BMI From Baseline(6 Months)
  • Change in Systolic Blood Pressure From 6 Months to 12 Months(12 Months)
  • Change in Diastolic Blood Pressure From 6 Months to 12 Months(12 Months)
  • Change in Summary of Diabetes Self-care Activities From Baseline(6 Months)
  • Change in Summary of Diabetes Self-care Activities From 6 Months to 12 Months(12 Months)
  • Change in Wilson 3 Item Scale From Baseline(6 Months)
  • Change in Healthcare Utilization From Baseline(6 Months)
  • Change in Fatalism From 6 Months to 12 Months(12 Months)
  • Change in WHO Quality of Life From Baseline(6 Months)
  • Change in Norbeck Social Support Questionnaire From Baseline(6 Months)
  • Change in Wilson 3 Item Scale From 6 Months to 12 Months(12 Months)
  • Change in Diabetes Distress Scale From Baseline(6 Months)
  • Change in Diabetes Family Behavior Checklist Nonsupportive From 6 Months to 12 Months(12 Months)
  • Change in Diabetes Care Profile Support From 6 Months to 12 Months(12 Months)
  • Change in Diabetes Empowerment Scale Short Form From Baseline(6 Months)
  • Change in Diabetes Distress Scale From 6 Months to 12 Months(12 Months)
  • Change in Patient Health Questionnaire 9 From 6 Months to 12 Months(12 Months)
  • Change in Diabetes Family Behavior Checklist - Supportive From Baseline(6 Months)
  • Change in Diabetes Family Behavior Checklist Supportive From 6 Months to 12 Months(12 Months)
  • Change in Diabetes Empowerment Scale Short Form From 6 Months to 12 Months(12 months)
  • Change in WHO Quality of Life From 6 Months to 12 Months(12 Months)
  • Change in Diabetes Family Behavior Checklist - Nonsupportive From Baseline(6 Months)
  • Change in Norbeck Social Support Questionnaire From 6 Months to 12 Months(12 Months)
  • Change in Patient Health Questionnaire 9 From Baseline(6 Months)
  • Change in Partner Distress Scale From Baseline(6 Months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Elizabeth Burner

Assistant Professor of Clinical Emergency Medicine

University of Southern California

Study Sites (1)

Loading locations...

Similar Trials